Unraveling the mechanisms of cell-mediated Chlamydia systemic dissemination.
揭示细胞介导的衣原体系统传播的机制。
基本信息
- 批准号:10517514
- 负责人:
- 金额:$ 21.62万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-11-01 至 2024-10-31
- 项目状态:已结题
- 来源:
- 关键词:AnimalsAntibodiesAutomobile DrivingCCL1 geneCCL19 geneCCL21 geneCCL8 geneCCR8 geneCD8-Positive T-LymphocytesCell Migration Inhibition functionCellsCervicitisCharacteristicsChlamydiaChlamydia InfectionsChlamydia muridarumChlamydia trachomatisCirculationCommon iliac lymph nodeCytolysisDevelopmentEctopic PregnancyEndophthalmitisEpithelial CellsEquilibriumEventExcisionExhibitsFemaleFetusGastrointestinal tract structureGenomicsHIVHealthHumanHuman PapillomavirusImmunityImmunobiologyImmunoglobulin GIn SituInfantInfectionInfertilityInflammatoryInternal MigrationsKnowledgeLifeMacrophageMalignant neoplasm of cervix uteriMediatingModelingMusNeonatalPathogenesisPathologyPelvic Inflammatory DiseasePhasePhenotypePneumoniaPregnant WomenProliferatingReportingReproductive Tract InfectionsRiskRoleSalpingitisSerumSexual TransmissionSexually Transmitted DiseasesSignal TransductionSiteSpleenSyntenyT-LymphocyteTestingTissuesTransgenic MiceVacuoleVaginaWomanWorkantagonistcell motilitycell typechemokinechemokine receptorchronic pelvic painembryo/fetus antigengastrointestinal infectionimprovedmigrationmonocytemouse modelmucosal vaccinepathogenpathogenic bacteriapermissivenessreproductive tractsphingosine 1-phosphatetissue tropismtransmission processtubal infertilityvaccine developmentyoung woman
项目摘要
PROJECT SUMMARY/ABSTRACT
Recently WHO estimated that more than 1 million new STIs are acquired daily. In 2016 of about 376 million
new STIs, 127 million were caused by Chlamydia. In the US, Chlamydia continues to be a leading cause of
STIs, with 1.7 million cases of approximately 2.3 million STIs reported in 2017. Chlamydial infections in women
may result in cervicitis, salpingitis, pelvic inflammatory disease, causing infertility or life-threatening ectopic
pregnancy. Moreover, chlamydial STIs in women are associated with increased transmission of HIV and an
increased risk of cervical cancer when co-infected with HPV. In spite of great efforts, the development of
mucosal vaccines that target Chlamydia has been unsuccessful. In the mouse model of infection, Chlamydia
spreads from the female reproductive tract (FRT) to infect and persist in the gastro-intestinal tract (GIT). GIT
infections with Chlamydia also occur in humans. In mice, following FRT infection Chlamydia muridarum (Cm)
disseminates systemically in stages, by first infecting the FRT-draining iliac lymph nodes (ILNs), then the
spleen, and the GIT. Cm dissemination relies on carriage by migrating host cells. Inhibition of cell migration in
CCR7-/- mice or in mice treated with FTY720 diminishes or abrogates Cm spread to the spleen and the GIT.
Moreover, removal of the spleen drastically reduces Cm infection of the GIT. Most importantly, removal of the
spleen hinders Cm ascension in the upper FRT and abrogates the FRT pathology. We hypothesize that the
spleen is a permissive site for Cm proliferation and that circulating infected cells contribute to Cm spread to the
upper FRT. Therefore, the knowledge gained from the proposed work will improve our understanding of FRT
immunobiology, cell migration, Chlamydia pathogenesis, and will be important for the development of vaccines
and therapies to target this pathogen.
项目摘要/摘要
最近,谁估计每天收购超过100万个新的传播感染。 2016年约3.76亿
新的性传播感染,1.27亿是由衣原体引起的。在美国,衣原体仍然是
性传播疾病,2017年报告约有170万例性传播感染性传播疾病。
可能导致宫颈炎,盐炎,盆腔炎症性疾病,导致不孕或威胁生命的异位
怀孕。此外,妇女的衣原体性传播疾病与艾滋病毒的传播增加有关
与HPV共同感染时,会增加宫颈癌的风险。尽管做出了巨大的努力,但
靶向衣原体的粘膜疫苗没有成功。在小鼠感染模型中
从女性生殖道(FRT)传播,以感染并持续存在于胃肠道(GIT)中。 git
对衣原体的感染也发生在人类中。在小鼠中,在FRT感染之后
通过首先感染dradantain dra的iLiac淋巴结(ILN),然后在阶段进行全身传播
脾脏和git。 CM传播通过迁移宿主细胞来依赖运输。抑制细胞迁移
CCR7 - / - 小鼠或用FTY720处理的小鼠减少或消除CM扩散到脾脏和GIT。
此外,脾脏的去除大大减少了GIT的CM感染。最重要的是,去除
脾脏阻碍了上FRT中的CM升高,并消除了FRT病理学。我们假设
脾脏是CM增殖的宽松部位,循环感染细胞有助于CM扩散到
上frt。因此,从拟议的工作中获得的知识将改善我们对FRT的理解
免疫生物学,细胞迁移,衣原体发病机理,对于疫苗的开发至关重要
和靶向这种病原体的疗法。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Vjollca H Konjufca其他文献
Vjollca H Konjufca的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Vjollca H Konjufca', 18)}}的其他基金
Unraveling the mechanisms of cell-mediated Chlamydia systemic dissemination.
揭示细胞介导的衣原体系统传播的机制。
- 批准号:
10373533 - 财政年份:2021
- 资助金额:
$ 21.62万 - 项目类别:
Characterization of "serosal bridges": routes for antigen and pathogen transport from the female reproductive tract to the intestines.
“浆膜桥”的表征:抗原和病原体从女性生殖道运输到肠道的途径。
- 批准号:
9375062 - 财政年份:2017
- 资助金额:
$ 21.62万 - 项目类别:
相似国自然基金
人源化小鼠筛选猴痘抗体及机制研究
- 批准号:82373778
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
抗HTNV抗体mRNA修饰MSC在肾综合征出血热治疗中的作用研究
- 批准号:82302487
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
人和小鼠中新冠病毒RBD的免疫原性表位及其互作抗体的表征和结构组学规律的比较研究
- 批准号:32371262
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
靶向肿瘤内T细胞的双特异性抗体治疗策略研究
- 批准号:82371845
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
靶向DLL3和γδ T细胞的双特异抗体对小细胞肺癌的免疫治疗活性研究
- 批准号:32300783
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
The Serine Protease HTRA1 Antigen: A Gateway to Elucidating Membranous Nephropathy Pathogenesis and the Targeting of Antigen Epitopes
丝氨酸蛋白酶 HTRA1 抗原:阐明膜性肾病发病机制和抗原表位靶向的途径
- 批准号:
10740614 - 财政年份:2023
- 资助金额:
$ 21.62万 - 项目类别:
The role of SH2B3 in regulating CD8 T cells in Type 1 Diabetes
SH2B3 在 1 型糖尿病中调节 CD8 T 细胞的作用
- 批准号:
10574346 - 财政年份:2023
- 资助金额:
$ 21.62万 - 项目类别:
Development of a targeted TGF-b therapeutic that selectively blocks lung fibrosis in idiopathic pulmonary fibrosis (IPF) patients
开发选择性阻断特发性肺纤维化 (IPF) 患者肺纤维化的靶向 TGF-b 疗法
- 批准号:
10697961 - 财政年份:2023
- 资助金额:
$ 21.62万 - 项目类别:
Bispecific immunotherapeutic delivery system for lung diseases
用于肺部疾病的双特异性免疫治疗递送系统
- 批准号:
10720773 - 财政年份:2023
- 资助金额:
$ 21.62万 - 项目类别:
Project 2: Microbial determinants of HIV broadly-neutralizing antibody precursor induction in infants
项目2:婴儿中HIV广泛中和抗体前体诱导的微生物决定因素
- 批准号:
10731282 - 财政年份:2023
- 资助金额:
$ 21.62万 - 项目类别: